Clinical Trials Browser

Phase 1/2 × OTHER × Hearing Loss × Clear all

NCT07407582 2026-02-12

Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)

Phase 1/2 Not yet recruiting

GenitourinaryHead & Neck

Head and Neck Neoplasms, Neoplasms, Testicular Neoplasms, Hearing Loss

NCT04291209 2023-09-06

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Phase 1/2 Unknown

Deafness, Ear Diseases, Hearing Loss, Sensorineural, Hearing Loss